Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Seroma 2Postoperative Hemorrhage 2Leiomyoma 2Hemorrhage 2Blood Loss, Surgical 2Wrist Fractures 1Thromboembolism 1Stomach Neoplasms 1Sarcoma 1Polyposis, Gastric 1Ovarian Neoplasms 1Menorrhagia 1Meningioma 1Hematoma 1Hand Injuries 1Esophageal Neoplasms 1Edema 1Dupuytren Contracture 1Duodenal Neoplasms 1Disease 1Colorectal Surgery 1Colonic Neoplasms 1

Interventions

Bismuth 6Esomeprazole 5Amoxicillin 5Tetracycline 4Oxaliplatin 4apatinib 3Irinotecan 3Furazolidone 3Fluorouracil 3Clarithromycin 3fish oil triglycerides 2Rabeprazole 2Leucovorin 2Indocyanine Green 2Berberine 2sintilimab 1potassium oxonate 1lenvatinib 1iron isomaltoside 1000 1ilaprazole 1gimeracil 1ferric carboxymaltose 1doxifluridine 1alanylglutamine 1Water 1Trastuzumab 1Tranexamic Acid 1Tobacco Use Cessation Devices 1Thalidomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Stomach Neoplasms × Tranexamic Acid × Clear all
NCT05688020 2023-08-09

Tranexamic Acid During Upper GI Endoscopic Resection Procedures

Assaf-Harofeh Medical Center

Phase 4 Unknown
200 enrolled
Gastrointestinal

Polyposis, Gastric, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡